BLFS vs. NTUS, LIVN, CNMD, INMD, SLNO, ZYXI, AXGN, EDAP, SMLR, and OM
Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Natus Medical (NTUS), LivaNova (LIVN), CONMED (CNMD), InMode (INMD), Soleno Therapeutics (SLNO), Zynex (ZYXI), AxoGen (AXGN), Edap Tms (EDAP), Semler Scientific (SMLR), and Outset Medical (OM). These companies are all part of the "medical" sector.
BioLife Solutions (NASDAQ:BLFS) and Natus Medical (NASDAQ:NTUS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends.
93.2% of BioLife Solutions shares are owned by institutional investors. Comparatively, 92.4% of Natus Medical shares are owned by institutional investors. 2.7% of BioLife Solutions shares are owned by company insiders. Comparatively, 1.2% of Natus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
BioLife Solutions presently has a consensus target price of $23.67, suggesting a potential upside of 10.18%. Given BioLife Solutions' higher possible upside, equities research analysts plainly believe BioLife Solutions is more favorable than Natus Medical.
BioLife Solutions has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500. Comparatively, Natus Medical has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500.
In the previous week, BioLife Solutions had 12 more articles in the media than Natus Medical. MarketBeat recorded 12 mentions for BioLife Solutions and 0 mentions for Natus Medical. Natus Medical's average media sentiment score of 0.59 beat BioLife Solutions' score of 0.46 indicating that Natus Medical is being referred to more favorably in the news media.
BioLife Solutions received 183 more outperform votes than Natus Medical when rated by MarketBeat users. However, 81.38% of users gave Natus Medical an outperform vote while only 66.74% of users gave BioLife Solutions an outperform vote.
Natus Medical has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Natus Medical, indicating that it is currently the more affordable of the two stocks.
Natus Medical has a net margin of 2.65% compared to BioLife Solutions' net margin of -45.84%. Natus Medical's return on equity of 10.15% beat BioLife Solutions' return on equity.
Summary
Natus Medical beats BioLife Solutions on 9 of the 17 factors compared between the two stocks.
Get BioLife Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioLife Solutions Competitors List
Related Companies and Tools
